Trade

with

Sanofi
(NYSE: SNY)
AdChoices
53.53
+0.90
+1.71%
After Hours :
53.54
+0.01
+0.02%

Open

53.37

Previous Close

52.63

Volume (Avg)

1.50M (1.18M)

Day's Range

53.21-53.85

52Wk Range

47.06-57.42

Market Cap.

141.41B

Dividend Rate (Yield )

1.91 (3.63%)

Beta

0.95

Shares Outstanding

2.64B

P/E Ratio (EPS)

26.74 (1.96)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 42.06B

    • Net Income

    • 4.69B

    • Market Cap.

    • 141.41B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 12.50

    • PEG (Price/Earnings Growth) Ratio

    • 1.70

    • Beta

    • 0.95

    • Forward P/E

    • 10.25

    • Price/Sales

    • 3.41

    • Price/Book Value

    • 2.17

    • Price/Cash flow

    • 14.53

      • EBITDA

      • 13.62B

      • Return on Capital %

      • 4.41

      • Return on Equity %

      • 7.69

      • Return on Assets %

      • 4.41

      • Book Value/Share

      • 31.41

      • Shares Outstanding

      • 2.64B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 1.91 (5/7/2014)

      • Dividend Declaration Date

      • 2/12/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 64.08

        • Credit Rating

        • AA-

        • Analysts

        • 3

        • EPS Estimate

        • 5.88

        • Cashflow Estimate

        • 7.13

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.70

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -25.20

          • -26.33

          • Net Income

            Q/Q (last year)

          • 73.40

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 2.94

          • -5.42

          • Net Income

            5-Year Annual Average

          • -2.80

          • 3.16

          • Dividends

            5-Year Annual Average

          • -0.96

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 67.12

            • 64.72

            • Pre-Tax Margin

            • 15.92

            • 13.77

            • Net Profit Margin

            • 12.50

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 70.40

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 16.50

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 15.10

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.18

              • 0.33

              • Current Ratio

              • 1.71

              • 1.52

              • Quick Ratio

              • 1.24

              • 0.87

              • Interest Coverage

              • 9.89

              • 6.77

              • Leverage Ratio

              • 1.69

              • 1.91

              • Book Value/Share

              • 24.92

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 26.18

                • 65.36

                • P/E Ratio 5-Year High

                • 29.06

                • 237.47

                • P/E Ratio 5-Year Low

                • 14.18

                • 19.71

                • Price/Sales Ratio

                • 3.28

                • 3.63

                • Price/Book Value

                • 2.08

                • 3.39

                • Price/Cash Flow Ratio

                • 14.53

                • 21.83

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 7.69

                    (9.60)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 4.41

                    (5.70)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 6.73

                    (8.60)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 36.93k

                  • 27.79k

                  • Inventory Turnover

                  • 1.60

                  • 1.80

                  • Asset Turnover

                  • 0.35

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  6.45B
                  Operating Margin
                  15.33
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  14.53
                  Ownership

                  Institutional Ownership

                  9.37%

                  Top 10 Institutions

                  5.57%

                  Mutual Fund Ownership

                  4.82%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dodge & Cox Stock Fund

                  •  

                    27,088,029

                  • -1.03

                  • 1.03

                  • Vanguard Windsor™ II Fund

                  •  

                    18,904,300

                  • 0.00

                  • 0.72

                  • Franklin Income Fund

                  •  

                    14,000,000

                  • -6.67

                  • 0.53

                  • Oakmark Fund

                  •  

                    5,670,000

                  • 14.55

                  • 0.21

                  • Dodge & Cox Balanced Fund

                  •  

                    5,115,165

                  • 0.00

                  • 0.19

                  • Invesco Comstock

                  •  

                    3,685,736

                  • 15.83

                  • 0.14

                  • American Beacon Large Cap Value Fund

                  •  

                    3,511,100

                  • 0.00

                  • 0.13

                  • Invesco Charter Fund

                  •  

                    2,643,319

                  • 0.00

                  • 0.10

                  • Robeco US Premium Equities

                  •  

                    2,387,920

                  • -0.82

                  • 0.09

                  • Vanguard PrimeCap Fund

                  •  

                    1,485,000

                  • 20.24

                  • 0.06

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dodge & Cox

                  •  

                    43,549,909

                  • -0.26%

                  • 1.65

                  • Barrow, Hanley, Mewhinney & Strauss LLC.

                  •  

                    28,526,802

                  • +2.65%

                  • 1.08

                  • Franklin Advisers, Inc.

                  •  

                    18,615,437

                  • +26.97%

                  • 0.70

                  • Fisher Asset Management, LLC

                  •  

                    13,145,647

                  • +0.51%

                  • 0.50

                  • Invesco Advisers, Inc

                  •  

                    11,739,960

                  • +15.48%

                  • 0.44

                  • Hotchkis & Wiley Capital Management LLC

                  •  

                    9,772,061

                  • -0.33%

                  • 0.37

                  • Robeco Investment Management, Inc.

                  •  

                    6,316,796

                  • -43.54%

                  • 0.24

                  • Fidelity Management and Research Company

                  •  

                    5,452,600

                  • -7.77%

                  • 0.21

                  • Harris Associates L.P.

                  •  

                    5,025,750

                  • +90.26%

                  • 0.19

                  • Manning & Napier Advisors, LLC

                  •  

                    5,024,798

                  • +69.69%

                  • 0.19

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Speculative Growth

                  Style

                  Large Core

                  Sanofi was incorporated under the laws of France in 1994 as a société anonyme, a form of limited liability company. It is a healthcare company, engaged in the research, development, manufacture and marketing of healthcare products. I...morets principal activities include Pharmaceuticals, Human Vaccines via Sanofi Pasteur, and Animal Health via Merial. It also operates through the following platforms: Emerging Markets, Diabetes Solutions, Vaccines, Consumer Health Care (CHC), Animal Health, Genzyme, and Other Innovative Products. The Pharmaceuticals segment covers research, development, production and marketing of medicines, including activities acquired with Genzyme. Sanofi's pharmaceuticals portfolio consists of flagship products, plus prescription medicines, generic medicines, and consumer health product...mores. This segment also includes all associates and joint ventures whose activities are related to pharmaceuticals, in particular the entities majority owned by BMS. The Vaccines segment is wholly dedicated to vaccines, including research, development, production and marketing. This segment includes Sanofi Pasteur MSD joint venture with Merck & Co., Inc. in Europe. The Animal Health segment comprises the research, development, production and marketing activities of Merial, which offers medicines and vaccines for a wide variety of animal species. Its competitors include Novo Nordisk, Merck, Eli Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Shire, Pfizer, Biogen Idec, Teva and Merck Serono, Bayer, Roche, Johnson & Johnson, AstraZeneca, Boehringer-Ingelheim, Fresenius Medical Care, among others. The Company’s products and manufacturing facilities are subject to significant government regulations and approvals.lessless

                  Key People

                  Dr. David P. Meeker,M.D.

                  CEO, Divisional/Executive VP

                  Christopher Viehbacher

                  Director/CEO

                  Mr. Jerome Contamine

                  CFO/Executive VP

                  Karen Linehan

                  General Counsel/Executive VP, Divisional

                  Olivier Charmeil

                  Executive VP, Divisional

                  • Sanofi

                  • 54, Rue La Boétie

                  • Paris, 75008

                  • FRA.Map

                  • Phone: +33 153774000

                  • Fax: +33 153774463

                  • sanofi.com

                  Incorporated

                  1994

                  Employees

                  112,128

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: